KemPharm Inc. (KMPH)
NASDAQ: KMPH
· Real-Time Price · USD
5.81
-0.02 (-0.34%)
At close: Feb 28, 2023, 10:00 PM
KemPharm Revenue Breakdown
| Period Ending | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Jun 30, 2021 | Mar 31, 2021 | Jun 30, 2020 | Dec 31, 2019 | Sep 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License Revenue | 1.3M | 900K | 10.7M | 600K | 500K | 200K | 100K | 100K | 10M | 10M | 5M | n/a | 10M |
| License Revenue Growth | +44.44% | -91.59% | +1683.33% | +20.00% | +150.00% | +100.00% | 0.00% | -99.00% | 0.00% | +100.00% | n/a | -100.00% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 20.78M | 19.55M | 35.21M | 16.21M | 12.6M | 5.82M | 7M | 6.83M | 5.08M | 3.97M | 3.56M | 2.73M | 2.56M | 1.95M | 2.31M | 1.89M | 2.53M | 1.43M | 1.72M | 2.25M | 1.38M | 3.61M | 2.99M | 2.84M | 2.96M | 2.99M | 3.42M | 3.13M | 2.61M | 3.32M | 3.57M | 3.27M | 2.87M | 6.11M | 4.29M | 3.74M | 2.57M | 2.15M | 3.19M | 977K |
| Selling, General, and Administrative Revenue Growth | +6.33% | -44.49% | +117.24% | +28.59% | +116.64% | -16.95% | +2.50% | +34.61% | +27.76% | +11.69% | +30.14% | +6.96% | +31.21% | -15.49% | +21.83% | -25.16% | +76.91% | -16.87% | -23.43% | +63.15% | -61.92% | +20.88% | +5.32% | -4.25% | -0.94% | -12.51% | +9.20% | +19.82% | -21.24% | -7.13% | +9.43% | +13.68% | -53.01% | +42.62% | +14.75% | +45.60% | +19.24% | -32.50% | +226.31% | n/a |
| Research and Development Revenue | 3.43M | 3.26M | 13.52M | 10.95M | 10.52M | 12.3M | 7.43M | 8.84M | -11.31M | 5.38M | 4.79M | 3.08M | 2.81M | 2.24M | 2.85M | 2.27M | 3.05M | 1.71M | 1.95M | 2.13M | 2.46M | 3.62M | 4.8M | 8.53M | 6.3M | 13.33M | 10.49M | 11.64M | 5.54M | 6.29M | 4.65M | 4.11M | 7.96M | 4.29M | 4.99M | 3.23M | 4.72M | 4.33M | 2.77M | 2.12M |
| Research and Development Revenue Growth | +5.37% | -75.90% | +23.54% | +4.03% | -14.44% | +65.44% | -15.95% | -178.19% | -310.05% | +12.30% | +55.58% | +9.72% | +25.46% | -21.38% | +25.74% | -25.83% | +78.70% | -12.54% | -8.09% | -13.75% | -31.83% | -24.71% | -43.70% | +35.33% | -52.71% | +27.10% | -9.87% | +110.21% | -12.03% | +35.33% | +13.03% | -48.34% | +85.75% | -14.05% | +54.24% | -31.42% | +8.96% | +56.36% | +30.63% | n/a |